Literature DB >> 29124442

Neuropsychological profile in parents of adult phenylketonuria patients.

Gabriella Santangelo1, Fausta Piscopo2, Franco Santangelo3,4, Luigi Trojano2,5.   

Abstract

Phenylketonuria (PKU) is a disorder caused by an inborn error of metabolism, causing cognitive and behavioral disorders when not treated. Heterozygotes (i.e., patients' parents) were described with low verbal intelligence quotient, but no study systematically investigated cognitive functions in PKU parents. To obtain a neuropsychological profile in heterozygotes, we compared cognitive performance of heterozygotes and healthy controls (HC) on cognitive battery. Twelve heterozygotes and 14 HCs underwent standardized neuropsychological tasks assessing frontal/executive functions, memory, and visuospatial abilities. No significant difference between heterozygotes and HC was found on demographic aspects. Heterozygotes performed worse than HC on immediate verbal recall, on test assessing set-shifting, divided attention, and sensitivity to processing speed. No difference was found on the remaining cognitive tests.In conclusions, we observed less efficient control/executive functions in heterozygotes when compared to HCs. Further studies in large sample of heterozygotes should be performed to confirm our results.

Entities:  

Keywords:  Cognitive defects; Executive functions; Genetic disorders; Metabolic disorders; Mild cognitive impairment

Mesh:

Year:  2017        PMID: 29124442     DOI: 10.1007/s10072-017-3181-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  9 in total

1.  An fMRI study of the Trail Making Test.

Authors:  Konstantine K Zakzanis; Richard Mraz; Simon J Graham
Journal:  Neuropsychologia       Date:  2005-04-22       Impact factor: 3.139

Review 2.  Executive function in early-treated phenylketonuria: profile and underlying mechanisms.

Authors:  Shawn E Christ; Stephan C J Huijbregts; Leo M J de Sonneville; Desirée A White
Journal:  Mol Genet Metab       Date:  2010       Impact factor: 4.797

3.  Aberrant phenylalanine metabolism in phenylketonuria heterozygotes.

Authors:  P Guldberg; K F Henriksen; H C Lou; F Güttler
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

4.  Relationship between phenylalanine tolerance and psychological characteristics of phenylketonuric families.

Authors:  R O Fisch; P N Chang; L Sines; S Weisberg; S P Bessman
Journal:  Biochem Med       Date:  1985-04

5.  Diet, genetics, and mental retardation interaction between phenylketonuric heterozygous mother and fetus to produce nonspecific diminution of IQ: evidence in support of the justification hypothesis.

Authors:  S P Bessman; M L Williamson; R Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

6.  Phenylalanine metabolism and intellectual functioning among carriers of phenylketonuria and hyperphenylalaninaemia.

Authors:  R C Ford; J L Berman
Journal:  Lancet       Date:  1977-04-09       Impact factor: 79.321

7.  Processing speed is correlated with cerebral health markers in the frontal lobes as quantified by neuroimaging.

Authors:  P Kochunov; T Coyle; J Lancaster; D A Robin; J Hardies; V Kochunov; G Bartzokis; J Stanley; D Royall; A E Schlosser; M Null; P T Fox
Journal:  Neuroimage       Date:  2009-09-28       Impact factor: 6.556

8.  Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?

Authors:  Peter J Anderson; Stephen J Wood; Dorothy E Francis; Lee Coleman; Vicki Anderson; Avihu Boneh
Journal:  Dev Neuropsychol       Date:  2007       Impact factor: 2.253

9.  Cognitive outcomes in early-treated adults with phenylketonuria (PKU): A comprehensive picture across domains.

Authors:  Liana Palermo; Tarekegn Geberhiwot; Anita MacDonald; Ellie Limback; S Kate Hall; Cristina Romani
Journal:  Neuropsychology       Date:  2017-01-12       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.